Vaccines

29 Jul 2020 Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine
29 Jul 2020 Clinical phase about to begin
28 Jul 2020 Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study
27 Jul 2020 PDS Biotech Announces Preclinical Data for PDS0203, a T-Cell Activating Recombinant Protein Vaccine Against COVID-19
27 Jul 2020 Amyris and The Infectious Disease Research Institute Partner to Advance Novel RNA Vaccine Platform Beginning With COVID-19 Application
27 Jul 2020 Moderna Announces Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273) Begins
27 Jul 2020 MediciNova Announces SARS-CoV-2 Vaccine Joint Development with BioComo and Mie University Japan
27 Jul 2020 Moderna Announces Expansion of BARDA Agreement to Support Larger Phase 3 Program for Vaccine (mRNA-1273) Against COVID-19
23 Jul 2020 Dynavax and Medigen Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate
23 Jul 2020 Valneva Announces Positive Initial Results for Phase 2 Study of Lyme Disease Vaccine Candidate
22 Jul 2020 Transgene Reports Results From Clinical Study of TG4001 in Combination With Avelumab in Advanced HPV-Positive Cancers
22 Jul 2020 Pfizer and BioNTech Announce an Agreement with U.S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
22 Jul 2020 Preclinical Study Shows SARS-CoV-2 Spike Protein Licensed by Oragenics from the NIH Produces Neutralizing Antibodies
21 Jul 2020 Arcturus Therapeutics & Duke-NUS Received Approval to Proceed with Phase 1/2 Clinical Trial for COVID-19 Vaccine Candidate, LUNAR-COV19
20 Jul 2020 Metaclipse Therapeutics Awarded Funding from NIAID for COVID-19 Vaccine Development
20 Jul 2020 Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data
20 Jul 2020 COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trial
20 Jul 2020 GSK and CureVac announce strategic mRNA technology collaboration
20 Jul 2020 Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate against SARS-CoV-2
17 Jul 2020 Applied DNA and Takis Report Positive Preclinical Results from LineaDNA™ Vaccine Candidates for COVID-19
16 Jul 2020 Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant
16 Jul 2020 Virometix Announces Successful Closing of Series B Investment Round raising CHF 7.5 million
16 Jul 2020 AC Immune Advances phospho-Tau Alzheimer’s Vaccine in Phase 1b/2a Study
15 Jul 2020 COVAXX Announces First Multitope Peptide-Based Vaccine to Enter Human Trials
15 Jul 2020 ZYUS Announces Positive Milestone in Plant-Based COVID-19 Vaccine Antigen Production

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top